Jan 6, 2026 06:00AM Aclarion enrolls first patients at Northwestern, Scripps sites for CLARITY trial

Dec 4, 2025 08:02AM Aclarion publishes Nociscan article in spine surgery journal

Dec 2, 2025 08:01AM Aclarion names Jason Brosniak commercial director for eastern U.S.

Nov 5, 2025 06:00AM Aclarion hires Dan Isherwood as UK commercial director

Oct 14, 2025 06:11AM Aclarion reports 89% surge in scan volumes, advances trial

Oct 13, 2025 06:01AM Aclarion presents MR spectroscopy pain biomarker tech at London conference

Oct 9, 2025 06:00AM Aclarion to Present at the LD Micro Main Event XIX

Sep 19, 2025 03:36AM Aclarion, Inc. (ACON) PT Raised to $22 at Ascendiant Capital

Aug 5, 2025 06:01AM Aclarion reports 132% growth in Nociscan scan volume

Jul 7, 2025 04:02PM Aclarion (ACON) postpones annual shareholder meeting to July 21

May 30, 2025 05:48AM Aclarion, Inc. (ACON) PT Lowered to $20 at Ascendiant Capital for 1:27 Stock Split

Mar 31, 2025 07:03AM Aclarion (ACON) Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Mar 26, 2025 07:01AM Aclarion (ACON) Announces 1:27 Reverse Share Split

Mar 6, 2025 09:35AM Aclarion (ACON) Announces Expansion Plans with RadNet Affiliates in NY and NJ

Mar 3, 2025 07:08AM Aclarion (ACON) Announces First Commercial Agreement with Scripps Health

Feb 11, 2025 07:58AM Aclarion (ACON) Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy Data Processing

Feb 4, 2025 07:25AM Aclarion (ACON) Announces CLARITY Trial for Nociscan Now Fully Funded

Jan 31, 2025 12:00PM Aclarion (ACON) to Showcase NOCISCAN Technology at the Selby Spine Conference

Jan 28, 2025 11:01AM Aclarion (ACON) Announces Revised Split Ratio and Timing for Reverse Stock Split

Jan 15, 2025 09:31AM Aclarion (ACON) Prices 144M Share Offering at $0.10/sh

Nov 14, 2024 05:00PM Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Nov 4, 2024 06:22AM Aclarion (ACON) Files for 27.52M Share Offering by Selling Stockholders

Oct 25, 2024 05:11PM Aclarion (ACON) Files for 20M Share Offering by Selling Stockholders

Sep 27, 2024 06:57AM Aclarion's (ACON) Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Sep 24, 2024 05:02PM Aclarion (ACON) Enters $10M ATM

Sep 19, 2024 05:04PM Aclarion (ACON) Files $50M Mixed Shelf

Sep 12, 2024 06:57AM Aclarion (ACON) Provides Corporate Update on Nociscan AI Technology Milestones

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Sep 9, 2024 06:08AM Aclarion (ACON) Files $50M Mixed Shelf

Jul 29, 2024 03:35AM Ascendiant Capital Starts Aclarion, Inc. (ACON) at Buy

Jun 20, 2024 08:10AM Aclarion (ACON) Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution

Jun 18, 2024 07:10AM Aclarion (ACON) Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution